Barnaby Balmforth is the founder of Biofidelity. Biofidelity has raised $60M in total funding. Latest round: Series A+. Based in Cambridge, UK.
Barnaby Balmforth is the CEO and founder of Biofidelity, a biotechnology company established in 2019. The company focuses on developing blood-based diagnostic tests for early cancer detection and identifying genetic mutations. Under his leadership, Biofidelity has secured $60 million in total funding.
Full founder directory · Investor directory · Company funding database · Fundraising library